Brown, Lisle/Cummings’s Exelixis EXEL Stock Holding History

Brown, Lisle/Cummings’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$762	Hold	14	–	–	﹤0.01%	987
2026 Q1	$600	Buy	+14	New	+$602	﹤0.01%	972

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown, Lisle/Cummings's EXEL Position: Q2 2026 in Review

Brown, Lisle/Cummings held its Exelixis (EXEL) position steady in Q2 2026 at 14 shares worth $762. The position accounts for ﹤0.01% of the portfolio, ranked #987.

Brown, Lisle/Cummings first reported a position in EXEL in Q1 2026 and has held it in 2 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

Brown, Lisle/Cummings held 14 shares of Exelixis worth $762 as of Q2 2026.
Brown, Lisle/Cummings left its Exelixis share count unchanged in Q2 2026.
Exelixis made up ﹤0.01% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #987 holding.
Brown, Lisle/Cummings first reported a position in Exelixis in Q1 2026 and has held it in 2 quarters since.
758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.